Skip to main content
Clinical Trials/NCT05906719
NCT05906719
Recruiting
N/A

Machine Vision Based Machine Rating of MDS-UPDRS III

Ruijin Hospital8 sites in 1 country871 target enrollmentMarch 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinsonian Disorders
Sponsor
Ruijin Hospital
Enrollment
871
Locations
8
Primary Endpoint
Lin's CCC of machine rating vs gold standard rating
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The Movement Disorders Society (MDS) Unified Parkinson's Disease Rating Scale (UPDRS) Part III (MDS-UPDRS III) is the primary assessment method for motor symptoms in Parkinson's disease patients. Currently, movement disorder specialists conduct semi-quantitative scoring, which entails limitations such as subjectivity, weak sensitivity, and a limited number of professional physicians. This study, based on machine vision, establishes gold standard labels according to expert scoring. By using machine learning, we develop a machine rating model and compare the model's performance with gold standard rating and general clinical rating to investigate the accuracy of machine vision-based MDS-UPDRS III machine rating.

Registry
clinicaltrials.gov
Start Date
March 1, 2023
End Date
April 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Meeting the diagnostic criteria for Parkinsonism established by the International Movement Disorder Society: having bradykinesia, and meeting at least one of the two criteria for resting tremor or muscle rigidity
  • 20 to 80 years old
  • Good compliance, voluntarily joining the study, and able to sign an informed consent form or have it signed by a legal representative

Exclusion Criteria

  • Significant cognitive impairment (MMSE ≤ 23)
  • Unable to sign written informed consent or unable to complete the trial due to other reasons
  • Other situations in which the researcher deems the participant unsuitable for this study
  • Participation in other clinical trials

Outcomes

Primary Outcomes

Lin's CCC of machine rating vs gold standard rating

Time Frame: 1 day

The Lin's Concordance Correlation Coefficient when machine rating equals gold standard rating.

ACC0 of machine rating vs gold standard rating

Time Frame: 1 day

The accuracy rate when machine rating equals gold standard rating.

ACC1 of machine rating vs gold standard rating

Time Frame: 1 day

The accuracy rate when machine rating equals the range of gold standard rating plus or minus one.

Weighted kappa of machine rating vs gold standard rating

Time Frame: 1 day

The weighted kappa when machine rating equals gold standard rating.

Secondary Outcomes

  • Accuracy rate of machine rating vs general clinical rating(1 day)
  • Accuracy rate of machine facilitated rating vs general clinical rating(1 day)

Study Sites (8)

Loading locations...

Similar Trials